Improving vaccine stability for better global access
Official title: Enhancing Vaccine Thermostability with Natural Deep Eutectic Solvents
Funded at College at Oswego · NIH-10792289 · Data updated 2026-11-12
This study is working on new ways to keep vaccines stable so they can be stored at room temperature, making it easier to get them to people in areas that don’t have refrigeration, especially for vaccines like those for yellow fever and adenoviruses.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | College at Oswego NIH-funded |
| Lab location | 1 site (Oswego, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $459,551 |
| NIH project number | 1R15GM153057-01 |
| Project ID | NIH-10792289 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals in regions with limited access to refrigeration or those affected by vaccine shortages.
✕Less likely to help
Patients who already have reliable access to vaccines and refrigeration may not benefit from this research.
What this research studies
This research focuses on enhancing the stability of vaccines by developing new natural deep eutectic solvents that can allow vaccines to be stored at ambient temperatures without refrigeration. By addressing the challenges posed by the cold chain system, the project aims to reduce vaccine wastage and improve access to vaccines in underserved areas. The approach involves creating formulations that can be tailored to stabilize specific vaccine types, such as those for yellow fever and adenoviruses, thereby facilitating their distribution and use in various environments.
Why it matters
Potential benefit: If successful, this research could significantly increase global access to vaccines by reducing the need for refrigeration and minimizing wastage.
How similar studies have gone: Other research has shown promise in using innovative materials to enhance vaccine stability, suggesting that this approach could lead to meaningful advancements.
Where this research is happening
-
College at Oswego
Oswego, United States Active
Researchers
- Principal investigator: Mirjafari, Arsalan — College at Oswego
- Study coordinator: Mirjafari, Arsalan
Related research
Other NIH-funded projects on the same topics.
-
Aging hippocampus and cognitive control in health and MCI
This grant explores how aging affects memory-related brain function and thinking skills in older adults, including those with mild cognitive impairment.
-
How aging affects cognitive control in older adults and those with mild cognitive impairment
This study is looking at how getting older affects our ability to think and make decisions, especially for older adults with mild cognitive impairment, by exploring how a part of the brain called the hippocampus helps with these skills.
-
Improving the stability of vaccines using natural solvents
This study is looking at how special natural solvents can help keep viral vaccines effective even when they’re stored in tough temperature conditions, making it easier to get vaccines to people who need them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.